511 related articles for article (PubMed ID: 26214357)
1. Nanocarriers for delivery of siRNA and co-delivery of siRNA and other therapeutic agents.
Zhao J; Feng SS
Nanomedicine (Lond); 2015 Jul; 10(14):2199-228. PubMed ID: 26214357
[TBL] [Abstract][Full Text] [Related]
2. A review of nanocarriers for the delivery of small interfering RNA.
Kesharwani P; Gajbhiye V; Jain NK
Biomaterials; 2012 Oct; 33(29):7138-50. PubMed ID: 22796160
[TBL] [Abstract][Full Text] [Related]
3. Combinatorial therapeutic approaches with RNAi and anticancer drugs using nanodrug delivery systems.
Babu A; Munshi A; Ramesh R
Drug Dev Ind Pharm; 2017 Sep; 43(9):1391-1401. PubMed ID: 28523942
[TBL] [Abstract][Full Text] [Related]
4. Nanocarrier Mediated siRNA Delivery Targeting Stem Cell Differentiation.
Fernandes F; Kotharkar P; Chakravorty A; Kowshik M; Talukdar I
Curr Stem Cell Res Ther; 2020; 15(2):155-172. PubMed ID: 31789134
[TBL] [Abstract][Full Text] [Related]
5. Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges.
Gomes-da-Silva LC; Fonseca NA; Moura V; Pedroso de Lima MC; Simões S; Moreira JN
Acc Chem Res; 2012 Jul; 45(7):1163-71. PubMed ID: 22568781
[TBL] [Abstract][Full Text] [Related]
6. Polymers in the Co-delivery of siRNA and Anticancer Drugs for the Treatment of Drug-resistant Cancers.
Sun H; Yarovoy I; Capeling M; Cheng C
Top Curr Chem (Cham); 2017 Apr; 375(2):24. PubMed ID: 28176270
[TBL] [Abstract][Full Text] [Related]
7. Polymer nanocarriers for the delivery of small fragments of nucleic acids: oligonucleotides and siRNA.
de Martimprey H; Vauthier C; Malvy C; Couvreur P
Eur J Pharm Biopharm; 2009 Mar; 71(3):490-504. PubMed ID: 18977435
[TBL] [Abstract][Full Text] [Related]
8. Tumor-targeting multifunctional nanoparticles for siRNA delivery: recent advances in cancer therapy.
Ku SH; Kim K; Choi K; Kim SH; Kwon IC
Adv Healthc Mater; 2014 Aug; 3(8):1182-93. PubMed ID: 24577795
[TBL] [Abstract][Full Text] [Related]
9. Polymeric nanocarriers for siRNA delivery to murine macrophages.
Forbes DC; Peppas NA
Macromol Biosci; 2014 Aug; 14(8):1096-105. PubMed ID: 24753265
[TBL] [Abstract][Full Text] [Related]
10. In vivo delivery of small interfering RNA to tumors and their vasculature by novel dendritic nanocarriers.
Ofek P; Fischer W; Calderón M; Haag R; Satchi-Fainaro R
FASEB J; 2010 Sep; 24(9):3122-34. PubMed ID: 20385622
[TBL] [Abstract][Full Text] [Related]
11. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery.
Ma X; Zhao Y; Ng KW; Zhao Y
Chemistry; 2013 Nov; 19(46):15593-603. PubMed ID: 24123533
[TBL] [Abstract][Full Text] [Related]
12. Targeted Delivery of siRNA Therapeutics using Ligand Mediated Biodegradable Polymeric Nanocarriers.
Cho KS; Hong SJ; Ahn MH; Pal S; Choung PH; Sangshetti J; Arote RB
Curr Pharm Des; 2018; 24(16):1788-1800. PubMed ID: 29962332
[TBL] [Abstract][Full Text] [Related]
13. Cell-free synthesis of connexin 43-integrated exosome-mimetic nanoparticles for siRNA delivery.
Lu M; Zhao X; Xing H; Liu H; Lang L; Yang T; Xun Z; Wang D; Ding P
Acta Biomater; 2019 Sep; 96():517-536. PubMed ID: 31284098
[TBL] [Abstract][Full Text] [Related]
14. Reversal of multidrug resistance in vitro by co-delivery of MDR1 targeting siRNA and doxorubicin using a novel cationic poly(lactide-co-glycolide) nanoformulation.
Misra R; Das M; Sahoo BS; Sahoo SK
Int J Pharm; 2014 Nov; 475(1-2):372-84. PubMed ID: 25178825
[TBL] [Abstract][Full Text] [Related]
15. The potential and advances in RNAi therapy: chemical and structural modifications of siRNA molecules and use of biocompatible nanocarriers.
Joo MK; Yhee JY; Kim SH; Kim K
J Control Release; 2014 Nov; 193():113-21. PubMed ID: 24862319
[TBL] [Abstract][Full Text] [Related]
16. Polypeptide cationic micelles mediated co-delivery of docetaxel and siRNA for synergistic tumor therapy.
Zheng C; Zheng M; Gong P; Deng J; Yi H; Zhang P; Zhang Y; Liu P; Ma Y; Cai L
Biomaterials; 2013 Apr; 34(13):3431-8. PubMed ID: 23375952
[TBL] [Abstract][Full Text] [Related]
17. Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advances.
Gandhi NS; Tekade RK; Chougule MB
J Control Release; 2014 Nov; 194():238-56. PubMed ID: 25204288
[TBL] [Abstract][Full Text] [Related]
18. SiRNA delivery: challenges and role of carrier systems.
Shegokar R; Al Shaal L; Mishra PR
Pharmazie; 2011 May; 66(5):313-8. PubMed ID: 21699063
[TBL] [Abstract][Full Text] [Related]
19. Pharmaceutical nanotechnology for oral delivery of anticancer drugs.
Mei L; Zhang Z; Zhao L; Huang L; Yang XL; Tang J; Feng SS
Adv Drug Deliv Rev; 2013 Jun; 65(6):880-90. PubMed ID: 23220325
[TBL] [Abstract][Full Text] [Related]
20. Overcoming the Challenges of siRNA Delivery: Nanoparticle Strategies.
Shajari N; Mansoori B; Davudian S; Mohammadi A; Baradaran B
Curr Drug Deliv; 2017; 14(1):36-46. PubMed ID: 27538460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
